What is ICON plc's business focus and history?
ICON plc is a publicly traded company based in Dublin, Ireland, founded in 1990 by John Climax and Ronan Lambe. It operates as a world-leading healthcare intelligence and clinical research organisation, providing outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organisations. ICON plc has not raised any funding yet. The company has 158 active competitors, including 16 funded and 8 that have exited. Its top competitors include companies like Parexel, Covance, and Medpace.
ICON plc Corporate Details & Core Services
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, they advance clinical research by providing outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organisations. They develop new innovations, drive emerging therapies forward, and improve patient lives.
ICON plc Contact Information & Official Links
What are ICON plc's Key Business Metrics & Stats?
No of employees 41900
Founded year 1990
Type public
SAICS CODE 8731
NAICS Code 541715
Industry Healthcare
Location Dublin, Ireland
Subsidiary Company
prahs.com, docsglobal.com, medpass.org, molecularmd.com, pricespective.com
Stock Name ICLR (NASDAQ)
Other website iconplc.com
Pricing Strategy Custom pricing based on project scope and services required
ICON plc
ICLR (NASDAQ)
Firmographic Snapshot
2026
1990
Founded Year
41900
Global Employees
Ireland
Headquarters
Healthcare Industry
Public
Type
Verified by
DexterAgent.ai
How much funding has ICON plc raised to date?
Name
Description
Latest Valuation
20.4 Billion (USD)
What are ICON plc's Core Products?
Name
Description
Clinical & Scientific Operations
Planning, management, execution, and analysis of Phase I-IV clinical trials.
Decentralised Clinical Trials
End-to-end services and technology for decentralized clinical trials to improve patient recruitment and retention.
Laboratory Solutions
Bioanalytical, central, and specialty laboratory services dedicated to global clinical development.
What are the latest developments at ICON plc?
Date
Type
Description
May, 2024
Press Release
ICON releases its ICON Cares 2023 Report outlining ESG, diversity, inclusion, and CSR goals.
What industry awards and recognitions has ICON plc received?
Date
Type
Description
May, 2022
Award
Named Business & Finance Company of the Year and one of Forbes' Best Employers for Diversity.
ICON plc VS Parexel VS Covance VS Medpace : 2026 Comparison
Feature
ICON plc
Parexel
Covance
Medpace
Core Strengths Clinical & Scientific Operations, Decentralised Clinical Trials, Laboratory Solutions
Clinical Trial Management, Regulatory Consulting, Real World Evidence, Medical Communications
Xcellerate Monitoring
Clinical Trial Management, Central Laboratory Services, Bioanalytical Laboratory Services, Imaging Core Lab
Founded Year 1990
1982
1968
1992
Stock Name/Ticker ICLR (NASDAQ)
LH (NYSE)
MEDP (NASDAQ)
Type public
private
public
public
Global Employees 41900
24000
15500
6200
Revenue (Annual) $8.3 Billion(2024)
$2.3 Billion(2017)
$8.5 Billion(2014)
$2.5 Billion(2025)
Headquarters Dublin, Ireland
Raleigh, North Carolina, United States
Durham, North Carolina, United States
Cincinnati, Ohio, United States
Latest Valuation $20.4 Billion
$8.5 Billion
$0
$16.8 Billion
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
Parexel
2.3 | 24000
Covance
8.5 | 15500
Medpace
2.5 | 6200
Competitive Landscape 2026
DexterAgent.ai
What are ICON plc's official legal and registration details?
Name
Description
Legal Name
ICON plc
Cin number
GST number
Registration number
IE 201698
Who is in ICON plc's executive leadership team?
Name
Designation
CEO
Barry Balfe
Chief Financial Officer
Brendan Brennan
President of Development and Commercialisation Solutions
Dr. Nuala Murphy
Where are ICON plc's primary office locations?
City
Country
Dublin
Ireland
North Wales
USA
What are the current business signals and market intelligence for ICON plc?
Spending next 3 months
Technology integration, Expansion of decentralized clinical trials, Enhancing patient recruitment strategies
Pain points
Complexity of clinical trial management, Regulatory compliance challenges, Patient recruitment and retention difficulties
Sales motion
Direct sales to pharmaceutical and biotech companies, Strategic partnerships with medical device firms, Government contracts for public health research
Buyer Persona
Clinical Operations Managers, Regulatory Affairs Directors, R&D Executives
Type of customer
Pharmaceutical companies, Biotechnology firms, Medical device manufacturers, Government and public health organizations
Key customer domain
pfizer.com, novartis.com, johnsonandjohnson.com
Annual ACV
High-value contracts typically ranging from $1 million to $50 million
What is ICON plc's annual revenue history?
Year
Revenue (USD)
2024
8.3 Billion
What are ICON plc's risk management and compliance ratings?
GDPR RIsk
Yes
Privacy Risk
Yes
Company Ratings
4
Glassdoor Rating
3.8
Saas
No
Offline Stores
No
Service
Yes
Ecommerce
No
Exporter
Yes
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
No
Wholesale
No
Importer
No
